Evaluation of Marbofloxacin in Beagle Dogs After Oral Dosing: Preclinical Safety Evaluation and Comparative Pharmacokinetics of Two Different Tablets.

about

Evaluation of Marbofloxacin in Beagle Dogs After Oral Dosing: Preclinical Safety Evaluation and Comparative Pharmacokinetics of Two Different Tablets.

Item

http://www.wikidata.org/entity/Q54204498

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Evaluation of Marbofloxacin in ...... tics of Two Different Tablets.

@en

Evaluation of Marbofloxacin in ...... tics of Two Different Tablets.

@nl

type

Item

label

Evaluation of Marbofloxacin in ...... tics of Two Different Tablets.

@en

Evaluation of Marbofloxacin in ...... tics of Two Different Tablets.

@nl

prefLabel

Evaluation of Marbofloxacin in ...... tics of Two Different Tablets.

@en

Evaluation of Marbofloxacin in ...... tics of Two Different Tablets.

@nl

P1476

Evaluation of Marbofloxacin in ...... etics of Two Different Tablets

@en

P2093

Bing Yang

http://www.w3.org/2001/XMLSchema#string

Bowen Fan

http://www.w3.org/2001/XMLSchema#string

Jiyue Cao

http://www.w3.org/2001/XMLSchema#string

Qianying Liu

http://www.w3.org/2001/XMLSchema#string

Qigai He

http://www.w3.org/2001/XMLSchema#string

Saeed Ahmed

http://www.w3.org/2001/XMLSchema#string

Zhixin Lei

http://www.w3.org/2001/XMLSchema#string

P2860

Evaluation of the clinical efficacy of marbofloxacin (Zeniquin) tablets for the treatment of canine pyoderma: an open clinical trial.

Clinical Efficacy and Residue Depletion of 10% Enrofloxacin Enteric-Coated Granules in Pigs

Wild-type MIC distributions, epidemiological cutoff values and species-specific clinical breakpoints for fluconazole and Candida: time for harmonization of CLSI and EUCAST broth microdilution methods.

Safety of fluralaner chewable tablets (Bravecto), a novel systemic antiparasitic drug, in dogs after oral administration

Bioavailability and bioequivalence: an FDA regulatory overview.

Study on requirements of bioequivalence for registration of pharmaceutical products in USA, Europe and Canada

Integration of pharmacokinetic and pharmacodynamic indices of marbofloxacin in turkeys.

In vitro Dynamic Pharmacokinetic/Pharmacodynamic (PK/PD) study and COPD of Marbofloxacin against Haemophilus parasuis.

Ocular toxicity of fluoroquinolones.

BCS Biowaivers: Similarities and Differences Among EMA, FDA, and WHO Requirements.

P304

306

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FPHAR.2018.00306

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Haseeb Khaliq

P577

2018-04-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29692725

http://www.w3.org/2001/XMLSchema#string

P932

5903334

http://www.w3.org/2001/XMLSchema#string